Skip to main content

Day: April 12, 2023

Form 8.3 – [EMIS Group plc – 11 04 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Hydrocolloids Market is Expected to Grow $14.5 billion by 2028 – Exclusive Report by MarketsandMarkets™

The exponential growth in the natural and clean-label food consumption across the food and beverage industry due to its growing awareness has influenced the use of hydrocolloids. Chicago, April 12, 2023 (GLOBE NEWSWIRE) — According to MarketsandMarkets™, The global hydrocolloids market is estimated to be valued at USD 11.2 Billion in 2023. It is projected to reach USD 14.5 billion by 2028, recording a CAGR of 5.4% during the forecast period. The exponential growth in natural and clean-label food consumption across the food and beverage industry due to its growing awareness has influenced the use of hydrocolloids. Moreover, this has led to an increase in dependence on natural fibers and gums for functional properties, stability, safety, and quality of food products. Furthermore, hydrocolloid manufacturing companies follow...

Continue reading

Bloomage Biotech reports 28.53% YoY revenue increase, reaches $927.8 million in 2022

Bloomage Biotech 2022 Financial Report Bloomage Biotech reports 28.53% YoY revenue increase, reaches $927.8 million in 2022Parsippany, New Jersey, USA, April 12, 2023 (GLOBE NEWSWIRE) — Bloomage Biotech (688363.SH) released its 2022 Financial Report on March 30, 2023, posting a revenue of $924 million, an increase of 28.53% year-over-year (YoY). The net profit attributable to the owners of the parent company was $151 million, an increase of 24.11% YoY, and the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was $133 million, an increase of 28.46% YoY. During the reporting period, all four business segments of Bloomage Biotech experienced overall revenue growth and enhanced profitability due to increased scale. According to the annual report, the company’s raw materials...

Continue reading

Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights

– 2022 marks Ceapro’s best performance in Company history with record sales of $18,800,000 compared to $17,200,000 for 2021, representing a 10% increase year over year – Net profit after tax of $4,400,000 for the full year of 2022 compared to $3,400,000 in 2021, a year over year increase of 31% – R&D activities focused on advancement toward avenanthramide Phase 1-2a clinical study, development of innovative delivery systems with new chemical complexes and processing yeast beta glucan for development as an immune booster and potential inhalable therapeutic for lung fibrotic diseases – Continued execution on strategic plans position Ceapro for a transformational year in 2023 EDMONTON, Alberta, April 12, 2023 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO, OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company...

Continue reading

Powerdyne International Inc. Letter to The Shareholders

NORTH READING, Ma, April 12, 2023 (GLOBE NEWSWIRE) — Powerdyne International, Inc. (Ticker: PWDY) announces a letter to our Shareholders. Dear Shareholders We wanted to thank all our Shareholders for their patience and perseverance while Powerdyne International, Inc. (the “Company”, “Powerdyne”, “us”, “we”) was relisted on the OTC Markets. Our listing was completed on February 28, 2023, which allowed our shares to begin trading under the symbol (PWDY). Powerdyne has made major organizational changes, starting with two retirements from our management team Mr. Arthur Read, Executive Vice President and Director, along with Ms. Linda Madison Treasurer and Secretary to the Board of Directors. Both Arthur and Linda have been with Powerdyne since its inception, and I would like to thank them for their many years of dedicated service....

Continue reading

Introducing the Next Generation Chromatography Reagent for Advanced Separation and Analysis

SkyQuest’s Chromatography Reagent market report is an excellent analysis for individuals interested in gaining insight into the valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is written clearly and concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford, USA, April 12, 2023 (GLOBE NEWSWIRE) — SkyQuest projects that the Chromatography Reagent market will attain a value of USD 9.54 billion by 2030, with a CAGR of 6.8% over the forecast (2022-2030). The expansion of the market is determined by rising R&D expenditures for the pharmaceutical...

Continue reading

Oma Savings Bank Plc issues a EUR 250 million covered bond in a tap issue

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 12 APRIL 2023 AT 16:25 P.M. EET, OTHER INFORMATION DISCLOSED TO THE RULES OF THE EXCHANGEOma Savings Bank Plc issues a EUR 250 million covered bond in a tap issue NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NEW NOTES, THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oma Savings Bank Plc (”OmaSp” or “Company”) issues a EUR 250 million covered bond in a tap issue. The covered bond will be issued with same terms as the covered bond issued by OmaSp on 18 November 2020 and maturing on 25 November 2027. The loan to be issued now will...

Continue reading

Future Dao Enters into Definitive Merger Agreement with Metal Sky Star Acquisition Corporation

SINGAPORE and NEW YORK, April 12, 2023 (GLOBE NEWSWIRE) — Future Dao Group Holding Limited (“Future Dao”), a blockchain company with a focus on bitcoin mining, and Metal Sky Star Acquisition Corporation (Nasdaq: MSSA) (“MSSA”), a blank check company formed for the purpose of acquiring one or more businesses or entities, announced today that they have entered into a definitive merger agreement (the “Merger Agreement”). As contemplated by the Merger Agreement, following the closing of the merger (the “Proposed Transaction”), Future Dao will operate through a publicly-traded holding company listed on the Nasdaq Stock Market. Future Dao is in the process of establishing its Bitcoin mining operations in Central Asia. Future Dao intends to own and operate approximately 26,100 Bitcoin mining machines with an aggregate...

Continue reading

Verizon Business returns with 5G Innovation Session Tour, kicking-off in Chicago

Verizon Business launches the 2023 5G Innovation Session Tour with Ericsson at Soldier Field on April 19 BASKING RIDGE, N.J., April 12, 2023 (GLOBE NEWSWIRE) — Following a successful tour across six cities in 2022, Verizon Business is bringing back the 5G Innovation Sessions, a series of events that showcase the power of 5G through dynamic, immersive demonstrations of forward-looking use cases. Partnering with Ericsson for this first event, Verizon Business is kicking off the 2023 tour, planned for six cities, with a session at Chicago’s legendary Soldier Field. The first session will feature presentations, panels, and demonstrations by industry leaders and product experts from Verizon Business, Ericsson, Medivis, UC Davis Health, IBM and KSI Data Sciences. “The magic of 5G and edge computing comes to life when we put our heads...

Continue reading

Sixty-five Percent of Organizations Suffer from Data Bias, According to Progress Research Study

Most organizations understand the importance of mitigating data bias and believe it is prevalent within their businesses but struggle with how to address it effectively BURLINGTON, Mass., April 12, 2023 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of application development and infrastructure software, today announced the results of its global survey, “Data Bias: The Hidden Risk of AI”. Conducted by independent research firm, Insight Avenue, the Progress survey is based on interviews with more than 640 business and IT professionals, director level and above, who use data to make decisions and are using or plan to use artificial intelligence (AI) and machine learning (ML) to support their decision making. The full report and findings can be found here. Biases are often inherited by cultural and personal experiences....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.